Clinical effect of highly agglutinative staphylococcin and lentinan combined with cisplatin in treatment of malignant pleural effusion caused by lung cancer
Wanning TONG,Anshan ZHUO,Yushu CAO
DOI: https://doi.org/10.3969/j.issn.1672-4992.2011.11.33
2011-01-01
Journal of Modern Oncology
Abstract:Objective:To observe clinical therapeutic effectiveness and adverse reaction in the treatment of malignant pleural effusion(MPE)caused by lung cancer with highly agglutinative staphyloccocin and lentinan combined with cisplatin.Methods: To select 131 cases of lung cancer with MPE hospitalized patients from 2003 to 2008.The cases were divided into five groups: Group A,highly agglutinative staphyloccocin combined with cisplatin treatment 25 cases,Group B,lentinan combined with cisplatin treatment 27 cases,Group C,highly agglutinative staphyloccocin treatment alone 31 cases,Group D,lentinan treatment alone 25 cases;Group E,cisplatin treatment alone 23 cases.To use the one off central venous catheters to effuse.Results: The response rate in Group A was 84.00%,Group B 81.48%,Group C 54.84%,Group D 52%,Group E 52.17%;For Group A and B efficacy and quality of life was significantly better than the other groups,P<0.05;Group A and B had similar efficacy,Group C,D and E had similar efficacy P>0.05;all toxicities was mild and controllable;Group A and C in the incidence of fever was significantly higher than the other 3 groups,and had statistically significace(Group A compare with Group B,D,E,P<0.01;Group C compare with Group B,D,E,P<0.05),Other reaction was similar.Conclusion: Highly agglutinative staphylococcin and lentinan combined with cisplatin in the treatment of malignant pleural effusion caused by lung cancer is better than monotherapy,and adverse reactions were mild.